home All News open_in_new Full Article

Smart jab can shrink head and neck cancer tumours within six weeks, trial finds

Triple-action therapy drug amivantamab could be given as an injection to help treat recurrent or metastatic cancersDoctors have hailed “incredibly encouraging” trial results that show a triple-action smart jab can shrink tumours in head and neck cancer patients within six weeks.Head and neck cancer is the world’s sixth most common form of the disease. If it spreads or comes back after standard treatment, patients may be offered immunotherapy and platinum chemotherapy. But if this fails, there is often little else doctors can do. Continue reading...


today 22 h. ago attach_file Politics

attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Economics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Events
attach_file Politics
attach_file Politics
attach_file Events
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Economics
attach_file Economics
attach_file Science
attach_file Events


ID: 3441335312
Add Watch Country

arrow_drop_down